Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial-Reference-Cited by-同舟云学术

Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial

Published:2021-03-13 Issue:6 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Nouri‐Vaskeh Masoud¹²,Kalami Niusha³,Zand Ramin⁴,Soroureddin Zahra⁵,Varshochi Mojtaba⁶,Ansarin Khalil³,Rezaee Haleh⁶,Taghizadieh Ali³,Sadeghi Armin³,Ahangari Maleki Masoud³,Esmailnajad Azam³,Saleh Parviz⁷,Haghdoost Mehdi⁶,Maleki Mehdi⁸,Sharifi Akbar³^ORCID

Affiliation:

1. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN) Tehran Iran

3. Tuberculosis and Lung Disease Research Center Tabriz University of Medical Sciences Tabriz Iran

4. Department of Neurology Neuroscience InstituteGeisinger Health System Danville PA USA

5. Cardiovascular Division Imam Hossein HospitalShahid Beheshti University of Medical Sciences Tehran Iran

6. Tropical and Infectious Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran

7. Kidney Research Center Tabriz University of Medical Sciences Tabriz Iran

8. Cardiovascular Research Center Tabriz University of Medical Sciences Tabriz Iran

Funder

Tabriz University of Medical Sciences

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14124

Reference35 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

3. Fecal transmission in COVID‐19: A potential shedding route

4. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

5. Clinical characteristics of fatal cases of COVID‐19 in Tabriz, Iran: an analysis of 111 patients;Nouri‐Vaskeh M;Adv J Emerg Med,2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials;European Heart Journal - Cardiovascular Pharmacotherapy;2023-09-22

2. Reply to: RAAS inhibitors in COVID-19: Not all are created equal!;Revista Portuguesa de Cardiologia;2023-09

3. Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets;International Journal of Molecular Sciences;2023-05-15

4. Update Alert 10: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults;Annals of Internal Medicine;2023-05

5. RAAS-Hemmung und darüber hinaus – Herz-Kreislauf-Medikation bei Patienten mit einem Risiko für oder Erkrankung durch COVID-19;Herz;2023-04-25